Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD
Phase 3 Study of Standard Lipid Therapy Versus Intravenous Fat Emulsion Minimization for the Prevention of Parenteral Nutrition-Associated Liver Disease
Status: Enrolling
Updated:  12/31/1969
Seattle Children's Hospital
2005
mi
from 43215
Seattle, WA
Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD
Phase 3 Study of Standard Lipid Therapy Versus Intravenous Fat Emulsion Minimization for the Prevention of Parenteral Nutrition-Associated Liver Disease
Status: Enrolling
Updated: 12/31/1969
Seattle Children's Hospital
2005
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
A Study to Assess the Safety and Tolerability of Single Doses of AZD4076 in Healthy Male Subjects
A Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4076 Tetracosasodium Following Single-ascending Dose Administration to Healthy Male Subjects
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
344
mi
from 43215
Baltimore, MD
A Study to Assess the Safety and Tolerability of Single Doses of AZD4076 in Healthy Male Subjects
A Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4076 Tetracosasodium Following Single-ascending Dose Administration to Healthy Male Subjects
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy of Remimazolam in ASA III and IV Patients Undergoing Colonoscopy
A Study Evaluating the Safety and Efficacy of Remimazolam (CNS 7056) Compared to Placebo and Midazolam in ASA III and IV Patients Undergoing Colonoscopy
Status: Enrolling
Updated:  12/31/1969
Delta Research Partners, LLC
720
mi
from 43215
Monroe, LA
Safety and Efficacy of Remimazolam in ASA III and IV Patients Undergoing Colonoscopy
A Study Evaluating the Safety and Efficacy of Remimazolam (CNS 7056) Compared to Placebo and Midazolam in ASA III and IV Patients Undergoing Colonoscopy
Status: Enrolling
Updated: 12/31/1969
Delta Research Partners, LLC
720
mi
from 43215
Monroe, LA
Click here to add this to my saved trials
Safety and Efficacy of Remimazolam in ASA III and IV Patients Undergoing Colonoscopy
A Study Evaluating the Safety and Efficacy of Remimazolam (CNS 7056) Compared to Placebo and Midazolam in ASA III and IV Patients Undergoing Colonoscopy
Status: Enrolling
Updated:  12/31/1969
Jupiter Medical Center
916
mi
from 43215
Jupiter, FL
Safety and Efficacy of Remimazolam in ASA III and IV Patients Undergoing Colonoscopy
A Study Evaluating the Safety and Efficacy of Remimazolam (CNS 7056) Compared to Placebo and Midazolam in ASA III and IV Patients Undergoing Colonoscopy
Status: Enrolling
Updated: 12/31/1969
Jupiter Medical Center
916
mi
from 43215
Jupiter, FL
Click here to add this to my saved trials
Safety and Efficacy of Remimazolam in ASA III and IV Patients Undergoing Colonoscopy
A Study Evaluating the Safety and Efficacy of Remimazolam (CNS 7056) Compared to Placebo and Midazolam in ASA III and IV Patients Undergoing Colonoscopy
Status: Enrolling
Updated:  12/31/1969
Indiana University (Division of Gastroenterology/Hepatology)
166
mi
from 43215
Indianapolis, IN
Safety and Efficacy of Remimazolam in ASA III and IV Patients Undergoing Colonoscopy
A Study Evaluating the Safety and Efficacy of Remimazolam (CNS 7056) Compared to Placebo and Midazolam in ASA III and IV Patients Undergoing Colonoscopy
Status: Enrolling
Updated: 12/31/1969
Indiana University (Division of Gastroenterology/Hepatology)
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moderate Ulcerative Colitis
A Phase 1B Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moderate Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Community Clinical Research Network
618
mi
from 43215
Marlborough, MA
A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moderate Ulcerative Colitis
A Phase 1B Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moderate Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Community Clinical Research Network
618
mi
from 43215
Marlborough, MA
Click here to add this to my saved trials
Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease
Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Mercy Medical Center
344
mi
from 43215
Baltimore, MD
Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease
Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Mercy Medical Center
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease
Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Penn State Hershey Medical Center
337
mi
from 43215
Hershey, PA
Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease
Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Penn State Hershey Medical Center
337
mi
from 43215
Hershey, PA
Click here to add this to my saved trials
Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease
Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University
331
mi
from 43215
Nashville, TN
Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease
Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University
331
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease
Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
University of Maryland School of Medicine
343
mi
from 43215
Baltimore, MD
Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease
Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
University of Maryland School of Medicine
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Medication Adherence in Patients With Inflammatory Bowel Disease (IBD)
Assessment of Health Literacy, Medication Adherence, and a Pilot Multi-component Intervention to Improve Medication Adherence in Patients With Inflammatory Bowel Disease
Status: Enrolling
Updated:  12/31/1969
The Emory Clinic
432
mi
from 43215
Atlanta, GA
Medication Adherence in Patients With Inflammatory Bowel Disease (IBD)
Assessment of Health Literacy, Medication Adherence, and a Pilot Multi-component Intervention to Improve Medication Adherence in Patients With Inflammatory Bowel Disease
Status: Enrolling
Updated: 12/31/1969
The Emory Clinic
432
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Fetoscopic Endoluminal Tracheal Occlusion (FETO) for Congenital Diaphragm Hernia
Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Left Congenital Diaphragmatic Hernia (CDH)
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at Houston
990
mi
from 43215
Houston, TX
Fetoscopic Endoluminal Tracheal Occlusion (FETO) for Congenital Diaphragm Hernia
Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Left Congenital Diaphragmatic Hernia (CDH)
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at Houston
990
mi
from 43215
Houston, TX
Click here to add this to my saved trials
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Macks Research Group
1967
mi
from 43215
Newport Beach, CA
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Macks Research Group
1967
mi
from 43215
Newport Beach, CA
Click here to add this to my saved trials
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Medical Associates Research Associates
1947
mi
from 43215
San Diego, CA
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Medical Associates Research Associates
1947
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Florida Research Network
713
mi
from 43215
Gainesville, FL
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Florida Research Network
713
mi
from 43215
Gainesville, FL
Click here to add this to my saved trials
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
University of Miami School of Medicine
996
mi
from 43215
Miami, FL
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
University of Miami School of Medicine
996
mi
from 43215
Miami, FL
Click here to add this to my saved trials
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Gastroenterology Group of Naples
957
mi
from 43215
Naples, FL
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Gastroenterology Group of Naples
957
mi
from 43215
Naples, FL
Click here to add this to my saved trials
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Shafran Gastroenterology Center
791
mi
from 43215
Winter Park, FL
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Shafran Gastroenterology Center
791
mi
from 43215
Winter Park, FL
Click here to add this to my saved trials
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
University of Kentucky
154
mi
from 43215
Lexington, KY
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
University of Kentucky
154
mi
from 43215
Lexington, KY
Click here to add this to my saved trials
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Chevy Chase Clinical Research
324
mi
from 43215
Chevy Chase, MD
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Chevy Chase Clinical Research
324
mi
from 43215
Chevy Chase, MD
Click here to add this to my saved trials
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Dartmouth Hitchcock Medical Center
609
mi
from 43215
Lebanon, NH
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
609
mi
from 43215
Lebanon, NH
Click here to add this to my saved trials
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Concorde Medical Group
479
mi
from 43215
New York, NY
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Concorde Medical Group
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Rochester General Hospital
357
mi
from 43215
Rochester, NY
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Rochester General Hospital
357
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Case Western Reserve Univ
129
mi
from 43215
Cleveland, OH
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Case Western Reserve Univ
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Gastroenterology Center of the Midsouth
323
mi
from 43215
Germantown, TN
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Gastroenterology Center of the Midsouth
323
mi
from 43215
Germantown, TN
Click here to add this to my saved trials
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Nashville Gastrointestinal Specialists, Inc
332
mi
from 43215
Nashville, TN
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Nashville Gastrointestinal Specialists, Inc
332
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University
331
mi
from 43215
Nashville, TN
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University
331
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine
991
mi
from 43215
Houston, TX
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
McGuire Veterans Affairs Medical Center
342
mi
from 43215
Richmond, VA
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
McGuire Veterans Affairs Medical Center
342
mi
from 43215
Richmond, VA
Click here to add this to my saved trials
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Dean Medical Center
392
mi
from 43215
Madison, WI
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Dean Medical Center
392
mi
from 43215
Madison, WI
Click here to add this to my saved trials
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Multiprofile Hospotal for Active Treatment- Sveti Nikolay Chudotvoretz - LOM EOOD
mi
from 43215
Lom,
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Multiprofile Hospotal for Active Treatment- Sveti Nikolay Chudotvoretz - LOM EOOD
mi
from 43215
Lom,
Click here to add this to my saved trials
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Texas Digestive Disease Consultants - Dallas
910
mi
from 43215
Dallas, TX
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Texas Digestive Disease Consultants - Dallas
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Texas Digestive Disease Consultants - Southlake
919
mi
from 43215
Southlake, TX
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Texas Digestive Disease Consultants - Southlake
919
mi
from 43215
Southlake, TX
Click here to add this to my saved trials
Pharmacokinetic Study of Alpelisib in Subjects With Hepatic Impairment.
A Phase 1, Open-label, Single-dose, Multicenter, Parallel Group Study to Assess the Pharmacokinetics and Safety of Alpelisib (BYL719) in Subjects With Hepatic Impairment Compared to Matched Healthy Control Subjects.
Status: Enrolling
Updated:  12/31/1969
DaVita Clinical Research-Denver
1171
mi
from 43215
Lakewood, CO
Pharmacokinetic Study of Alpelisib in Subjects With Hepatic Impairment.
A Phase 1, Open-label, Single-dose, Multicenter, Parallel Group Study to Assess the Pharmacokinetics and Safety of Alpelisib (BYL719) in Subjects With Hepatic Impairment Compared to Matched Healthy Control Subjects.
Status: Enrolling
Updated: 12/31/1969
DaVita Clinical Research-Denver
1171
mi
from 43215
Lakewood, CO
Click here to add this to my saved trials
Pharmacokinetic Study of Alpelisib in Subjects With Hepatic Impairment.
A Phase 1, Open-label, Single-dose, Multicenter, Parallel Group Study to Assess the Pharmacokinetics and Safety of Alpelisib (BYL719) in Subjects With Hepatic Impairment Compared to Matched Healthy Control Subjects.
Status: Enrolling
Updated:  12/31/1969
University of Miami / Clinical Research Services, Inc.
996
mi
from 43215
Miami, FL
Pharmacokinetic Study of Alpelisib in Subjects With Hepatic Impairment.
A Phase 1, Open-label, Single-dose, Multicenter, Parallel Group Study to Assess the Pharmacokinetics and Safety of Alpelisib (BYL719) in Subjects With Hepatic Impairment Compared to Matched Healthy Control Subjects.
Status: Enrolling
Updated: 12/31/1969
University of Miami / Clinical Research Services, Inc.
996
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Pharmacokinetic Study of Alpelisib in Subjects With Hepatic Impairment.
A Phase 1, Open-label, Single-dose, Multicenter, Parallel Group Study to Assess the Pharmacokinetics and Safety of Alpelisib (BYL719) in Subjects With Hepatic Impairment Compared to Matched Healthy Control Subjects.
Status: Enrolling
Updated:  12/31/1969
Orlando Clinical Research Center
798
mi
from 43215
Orlando, FL
Pharmacokinetic Study of Alpelisib in Subjects With Hepatic Impairment.
A Phase 1, Open-label, Single-dose, Multicenter, Parallel Group Study to Assess the Pharmacokinetics and Safety of Alpelisib (BYL719) in Subjects With Hepatic Impairment Compared to Matched Healthy Control Subjects.
Status: Enrolling
Updated: 12/31/1969
Orlando Clinical Research Center
798
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Pharmacokinetic Study of Alpelisib in Subjects With Hepatic Impairment.
A Phase 1, Open-label, Single-dose, Multicenter, Parallel Group Study to Assess the Pharmacokinetics and Safety of Alpelisib (BYL719) in Subjects With Hepatic Impairment Compared to Matched Healthy Control Subjects.
Status: Enrolling
Updated:  12/31/1969
DaVita Clinical Research
625
mi
from 43215
Minneapolis, MN
Pharmacokinetic Study of Alpelisib in Subjects With Hepatic Impairment.
A Phase 1, Open-label, Single-dose, Multicenter, Parallel Group Study to Assess the Pharmacokinetics and Safety of Alpelisib (BYL719) in Subjects With Hepatic Impairment Compared to Matched Healthy Control Subjects.
Status: Enrolling
Updated: 12/31/1969
DaVita Clinical Research
625
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
Cardiometabolic Effects of Eplerenone in HIV Infection
Cardiometabolic Effects of Eplerenone in HIV Infection
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Cardiometabolic Effects of Eplerenone in HIV Infection
Cardiometabolic Effects of Eplerenone in HIV Infection
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
Physical Activity Interventions for Leg Ulcer Patients
Physical Activity Interventions for Leg Ulcer Patients
Status: Enrolling
Updated:  12/31/1969
Spartanburg Regional Medical Center
349
mi
from 43215
Spartanburg, SC
Physical Activity Interventions for Leg Ulcer Patients
Physical Activity Interventions for Leg Ulcer Patients
Status: Enrolling
Updated: 12/31/1969
Spartanburg Regional Medical Center
349
mi
from 43215
Spartanburg, SC
Click here to add this to my saved trials
Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)
A Phase 2, Randomized, Double Blind, Placebo Controlled Clinical Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Subjects With Nonalcoholic Steatohepatitis
Status: Enrolling
Updated:  12/31/1969
Scripps Clinic
1953
mi
from 43215
La Jolla, CA
Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)
A Phase 2, Randomized, Double Blind, Placebo Controlled Clinical Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Subjects With Nonalcoholic Steatohepatitis
Status: Enrolling
Updated: 12/31/1969
Scripps Clinic
1953
mi
from 43215
La Jolla, CA
Click here to add this to my saved trials
Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)
A Phase 2, Randomized, Double Blind, Placebo Controlled Clinical Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Subjects With Nonalcoholic Steatohepatitis
Status: Enrolling
Updated:  12/31/1969
Inland Empire Liver Foundation
1925
mi
from 43215
Rialto, CA
Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)
A Phase 2, Randomized, Double Blind, Placebo Controlled Clinical Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Subjects With Nonalcoholic Steatohepatitis
Status: Enrolling
Updated: 12/31/1969
Inland Empire Liver Foundation
1925
mi
from 43215
Rialto, CA
Click here to add this to my saved trials
Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)
A Phase 2, Randomized, Double Blind, Placebo Controlled Clinical Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Subjects With Nonalcoholic Steatohepatitis
Status: Enrolling
Updated:  12/31/1969
Nature Coast Clinical Research
772
mi
from 43215
Inverness, FL
Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)
A Phase 2, Randomized, Double Blind, Placebo Controlled Clinical Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Subjects With Nonalcoholic Steatohepatitis
Status: Enrolling
Updated: 12/31/1969
Nature Coast Clinical Research
772
mi
from 43215
Inverness, FL
Click here to add this to my saved trials
Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)
A Phase 2, Randomized, Double Blind, Placebo Controlled Clinical Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Subjects With Nonalcoholic Steatohepatitis
Status: Enrolling
Updated:  12/31/1969
University of Miamai, Schiff Center for Liver Diseases
992
mi
from 43215
Miami, FL
Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)
A Phase 2, Randomized, Double Blind, Placebo Controlled Clinical Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Subjects With Nonalcoholic Steatohepatitis
Status: Enrolling
Updated: 12/31/1969
University of Miamai, Schiff Center for Liver Diseases
992
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)
A Phase 2, Randomized, Double Blind, Placebo Controlled Clinical Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Subjects With Nonalcoholic Steatohepatitis
Status: Enrolling
Updated:  12/31/1969
Mercy Medical Center, Institute for Digestive Health & Liver Disease
344
mi
from 43215
Baltimore, MD
Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)
A Phase 2, Randomized, Double Blind, Placebo Controlled Clinical Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Subjects With Nonalcoholic Steatohepatitis
Status: Enrolling
Updated: 12/31/1969
Mercy Medical Center, Institute for Digestive Health & Liver Disease
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)
A Phase 2, Randomized, Double Blind, Placebo Controlled Clinical Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Subjects With Nonalcoholic Steatohepatitis
Status: Enrolling
Updated:  12/31/1969
Kansas City Research Institute
619
mi
from 43215
Kansas City, MO
Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)
A Phase 2, Randomized, Double Blind, Placebo Controlled Clinical Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Subjects With Nonalcoholic Steatohepatitis
Status: Enrolling
Updated: 12/31/1969
Kansas City Research Institute
619
mi
from 43215
Kansas City, MO
Click here to add this to my saved trials
Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)
A Phase 2, Randomized, Double Blind, Placebo Controlled Clinical Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Subjects With Nonalcoholic Steatohepatitis
Status: Enrolling
Updated:  12/31/1969
Cumberland Research Associates
406
mi
from 43215
Fayetteville, NC
Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)
A Phase 2, Randomized, Double Blind, Placebo Controlled Clinical Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Subjects With Nonalcoholic Steatohepatitis
Status: Enrolling
Updated: 12/31/1969
Cumberland Research Associates
406
mi
from 43215
Fayetteville, NC
Click here to add this to my saved trials
Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)
A Phase 2, Randomized, Double Blind, Placebo Controlled Clinical Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Subjects With Nonalcoholic Steatohepatitis
Status: Enrolling
Updated:  12/31/1969
Consultants for Clinical Research Inc.
98
mi
from 43215
Cincinnati, OH
Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)
A Phase 2, Randomized, Double Blind, Placebo Controlled Clinical Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Subjects With Nonalcoholic Steatohepatitis
Status: Enrolling
Updated: 12/31/1969
Consultants for Clinical Research Inc.
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)
A Phase 2, Randomized, Double Blind, Placebo Controlled Clinical Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Subjects With Nonalcoholic Steatohepatitis
Status: Enrolling
Updated:  12/31/1969
University Gastroenterology Liver Center
619
mi
from 43215
Providence, RI
Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)
A Phase 2, Randomized, Double Blind, Placebo Controlled Clinical Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Subjects With Nonalcoholic Steatohepatitis
Status: Enrolling
Updated: 12/31/1969
University Gastroenterology Liver Center
619
mi
from 43215
Providence, RI
Click here to add this to my saved trials
Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)
A Phase 2, Randomized, Double Blind, Placebo Controlled Clinical Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Subjects With Nonalcoholic Steatohepatitis
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)
A Phase 2, Randomized, Double Blind, Placebo Controlled Clinical Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Subjects With Nonalcoholic Steatohepatitis
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)
A Phase 2, Randomized, Double Blind, Placebo Controlled Clinical Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Subjects With Nonalcoholic Steatohepatitis
Status: Enrolling
Updated:  12/31/1969
Texas Clinical Research Institute
927
mi
from 43215
Arlington, TX
Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)
A Phase 2, Randomized, Double Blind, Placebo Controlled Clinical Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Subjects With Nonalcoholic Steatohepatitis
Status: Enrolling
Updated: 12/31/1969
Texas Clinical Research Institute
927
mi
from 43215
Arlington, TX
Click here to add this to my saved trials